Sulzer has agreed to acquire the Swiss-German Haselmeier Group for EUR 100 million. Closing of the transaction is planned for the fourth quarter of 2020. Haselmeier is a leading provider of patented injection systems such as subcutaneous
Tags :Jasmin Eicher
Walder Wyss acted as Swiss counsel to CRISPR in connection with the transaction. The team was led by partner Alex Nikitine. Homburger acted as legal counsel to Goldman Sachs & Co. LLC, BofA Securities, Inc. and
